UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050791
Receipt number R000057876
Scientific Title Iodine compound as postoperative eye drop following cataract surgery
Date of disclosure of the study information 2023/04/10
Last modified on 2023/04/09 08:43:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Iodine compound as postoperative eye drop following cataract surgery

Acronym

Iodine compound as postoperative eye drop following cataract surgery

Scientific Title

Iodine compound as postoperative eye drop following cataract surgery

Scientific Title:Acronym

Iodine compound as postoperative eye drop following cataract surgery

Region

Japan


Condition

Condition

cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

there is a concern about the risk of resistant bacteria when using postoperative antibiotic eye drops. Our study will verify whether safe management can be achieved by iodine eye drops without the risk of resistant bacteria.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in minimum inhibitory concentration of local bacteria in the eye 1 week and 1 month following surgery.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Comparison of antibiotics and Iodine following cataract surgery
using eye drops 3days a day for 1 week

Interventions/Control_2

Comparison of antibiotics and Iodine following cataract surgery
using eye drops 3days a day for 1 week

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients scheduled for cataract surgery

Key exclusion criteria

Patients using antibiotics within 3 months before surgery

Target sample size

100


Research contact person

Name of lead principal investigator

1st name kazuki
Middle name
Last name matsuura

Organization

nojima hospital

Division name

ophthalmology

Zip code

682-0863

Address

2714-1 sesakimachi kurayosi

TEL

0858226231

Email

matsu224@ncn-k.net


Public contact

Name of contact person

1st name matsuura
Middle name
Last name mastuura

Organization

Nojima Hospital

Division name

ophthalmology

Zip code

682-0863

Address

2714-1 sesakimachi kurayosi

TEL

+81858286676

Homepage URL


Email

matsu224@ncn-k.net


Sponsor or person

Institute

nojima hospital, ophthalmology, Kazuki Matsuura

Institute

Department

Personal name



Funding Source

Organization

Department of Ophthalmology, Tottoti University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nojima Hospital

Address

2714-1 sesakimachi kurayoshi

Tel

0858226231

Email

mastu224@ncn-k.net


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 20 Day

Date of IRB

2022 Year 12 Month 10 Day

Anticipated trial start date

2022 Year 12 Month 20 Day

Last follow-up date

2023 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 04 Month 09 Day

Last modified on

2023 Year 04 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057876